Edition:
United States

Titan Pharmaceuticals Inc (TTNP.OQ)

TTNP.OQ on NASDAQ Stock Exchange Capital Market

0.77USD
4:00pm EDT
Change (% chg)

$0.03 (+4.04%)
Prev Close
$0.74
Open
$0.78
Day's High
$0.78
Day's Low
$0.75
Volume
5,001
Avg. Vol
13,221
52-wk High
$2.80
52-wk Low
$0.60

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 2.67 -0.041
Mar '18 1.06 -0.123
FY 2017 Dec '17 0.06 -0.173
Sep '17 0.04 -0.198
Jun '17 0.08 -0.163
Mar '17 0.04 -0.142
FY 2016 Dec '16 0.04 -0.110
Sep '16 0.03 -0.124
Jun '16 15.00 0.545
Mar '16 0.00 -0.092
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 1 0.05 0.05 0.05 --
Quarter Ending Dec-18 1 0.05 0.05 0.05 --
Year Ending Dec-18 1 1.19 1.19 1.19 2.13
Year Ending Dec-19 1 0.55 0.55 0.55 5.39
Earnings (per share)
Quarter Ending Sep-18 1 -0.08 -0.08 -0.08 --
Quarter Ending Dec-18 1 -0.09 -0.09 -0.09 --
Year Ending Dec-18 1 -0.40 -0.40 -0.40 -0.45
Year Ending Dec-19 1 -0.30 -0.30 -0.30 -0.30
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.12 30.20
P/E High - Last 5 Yrs. 16.72 42.03 47.09
P/E Low - Last 5 Yrs. 5.15 23.72 24.83
Beta 1.28 0.87 0.85
Price to Sales (TTM) 4.98 3.58 8.01
Price to Book (MRQ) -- 3.34 3.71
Price to Tangible Book (MRQ) -- 4.81 5.64
Price to Cash Flow (TTM) -- 19.79 21.20
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.93 1.79
Dividend Yield - 5 Year Avg -- 1.54 1.46
Dividend 5 Year Growth Rate -- -9.11 -6.24
Payout Ratio(TTM) -- 49.41 46.65

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 3,364.94 4.60 7.19
Sales (TTM) vs TTM 1 Yr. Ago 2,051.69 10.08 11.35
Sales - 5 Yr. Growth Rate -50.34 6.99 7.60
EPS (MRQ) vs Qtr. 1 Yr. Ago 74.82 18.36 23.75
EPS (TTM) vs TTM 1 Yr. Ago 0.70 -- --
EPS - 5 Yr. Growth Rate -- 6.42 7.55
Capital Spending - 5 Yr. Growth Rate -31.42 7.50 8.07

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.20 2.55 2.52
Current Ratio (MRQ) 1.76 3.61 3.57
LT Debt to Equity (MRQ) -- 8.80 11.14
Total Debt to Equity (MRQ) -- 11.21 14.09
Interest Coverage (TTM) -- 36.51 31.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 67.83 55.52 55.05
Gross Margin - 5 Yr. Avg. -- 53.23 53.19
EBITD Margin (TTM) -262.45 -- --
EBITD - 5 Yr. Avg -63.30 18.75 15.79
Operating Margin (TTM) -273.89 14.49 -2.37
Operating Margin - 5 Yr. Avg. -68.49 14.39 10.97
Pre-Tax Margin (TTM) -295.69 14.77 -0.49
Pre-Tax Margin - 5 Yr. Avg. -42.29 14.63 11.14
Net Profit Margin (TTM) -295.69 11.39 -3.70
Net Profit Margin - 5 Yr. Avg. -42.29 10.93 7.49
Effective Tax Rate (TTM) -- 20.45 20.42
Effective Tax Rate - 5 Yr. Avg. -- 23.83 24.17

Efficiency

  Company industry sector
Revenue/Employee (TTM) 294,615 843,415,010 736,176,668
Net Income/Employee (TTM) -871,154 98,389,061 85,788,783
Receivable Turnover (TTM) 13.51 5.45 5.43
Inventory Turnover (TTM) -- 2.47 3.56
Asset Turnover (TTM) 0.55 0.86 0.84

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -161.43 10.46 10.17
Return on Assets - 5 Yr. Avg. -14.92 11.53 11.04
Return on Investment (TTM) -231.76 13.07 12.77
Return on Investment - 5 Yr. Avg. -27.41 14.95 14.26
Return on Equity (TTM) -363.86 15.04 14.92
Return on Equity - 5 Yr. Avg. -56.13 16.20 15.59
  1 Year 3 Year 5 Year
Sales % -98.57 -61.08 -50.34
EPS (TTM) % -381.98 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Titan Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 7.14%
# of Holders: 42
Total Shares Held: 1,514,292
3 Mo. Net Change: -94,662
# New Positions: 5
# Closed Positions: 6
# Increased Positions: 10
# Reduced Positions: 14
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.